Daré Bioscience höll sin telefonkonferens för det första kvartalet 2026 den 14 maj för att diskutera finansiella resultat och affärsuppdateringar med fokus på produkter för kvinnohälsa.
Daré Bioscience, Inc. höll konferenssamtalet klockan 16:30 EDT för att gå igenom resultaten för kvartalet som avslutades den 31 mars 2026. Chief Accounting Officer MarDee Haring-Layton inledde sessionen och presenterade VD Sabrina Johnson som huvudtalare tillsammans med henne.
Cytek Biosciences released its financial results for the first quarter of 2026 on May 7. The company then hosted an earnings conference call the same day at 4:30 PM EDT.
Rapporterad av AI
BioMarin Pharmaceutical Inc. conducted its first-quarter 2026 earnings conference call on May 4, 2026. Company executives, including CEO Alexander Hardy, presented financial results and updates. The call included forward-looking statements and non-GAAP measures.
ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.
Rapporterad av AI
PureCycle Technologies conducted its first quarter 2026 corporate update conference call on May 6. The session featured the company's top executives reviewing recent developments.